Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.95
+0.21 (3.12%)
At close: Nov 21, 2024, 4:00 PM
7.19
+0.24 (3.45%)
After-hours: Nov 21, 2024, 4:47 PM EST
Vir Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -533.34 | -615.06 | 515.84 | 528.58 | -298.67 | -174.68 | Upgrade
|
| Depreciation & Amortization | 16.15 | 19.45 | 6.78 | 5.81 | 5.44 | 3.29 | Upgrade
|
| Other Amortization | - | - | - | - | - | 1.22 | Upgrade
|
| Asset Writedown & Restructuring Costs | 35.02 | 17.32 | - | - | 0.83 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 9.93 | 13.18 | 102.2 | -138.29 | 1.55 | -0.18 | Upgrade
|
| Stock-Based Compensation | 90.89 | 111.32 | 102.08 | 83.78 | 27.6 | 8.72 | Upgrade
|
| Other Operating Activities | 14.47 | -20.4 | 270.99 | 100.92 | 42.78 | 23.79 | Upgrade
|
| Change in Accounts Receivable | -0.57 | -0.57 | 770.04 | -773.08 | - | - | Upgrade
|
| Change in Accounts Payable | 3.58 | 0.73 | 0.8 | -0.17 | -0.79 | 0.96 | Upgrade
|
| Change in Unearned Revenue | -53.32 | -2.35 | -33.3 | 92.04 | -7.04 | 3.53 | Upgrade
|
| Change in Other Net Operating Assets | -49.44 | -302.41 | -72.17 | 52.82 | 37.36 | 3.71 | Upgrade
|
| Operating Cash Flow | -466.64 | -778.79 | 1,663 | -47.59 | -190.94 | -129.63 | Upgrade
|
| Capital Expenditures | -6.43 | -21.57 | -68.01 | -21.82 | -6.55 | -8.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.92 | - | - | - | 0.18 | - | Upgrade
|
| Investment in Securities | 259.74 | 186.2 | -1,125 | -119 | -3.49 | -247.22 | Upgrade
|
| Investing Cash Flow | 253.82 | 164.63 | -1,193 | -140.81 | -9.86 | -256.16 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.2 | Upgrade
|
| Long-Term Debt Repaid | - | -0.29 | -0.26 | -0.26 | -0.25 | -0.1 | Upgrade
|
| Net Debt Issued (Repaid) | -0.27 | -0.29 | -0.26 | -0.26 | -0.25 | 1.11 | Upgrade
|
| Issuance of Common Stock | 5.07 | 7.77 | 36.22 | 100.59 | 555.76 | 130.81 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0 | Upgrade
|
| Other Financing Activities | - | - | -1.2 | - | -26.03 | - | Upgrade
|
| Financing Cash Flow | 4.81 | 7.48 | 34.76 | 100.33 | 529.47 | 449.24 | Upgrade
|
| Net Cash Flow | -208.02 | -606.68 | 504.55 | -88.07 | 328.67 | 63.45 | Upgrade
|
| Free Cash Flow | -473.07 | -800.36 | 1,595 | -69.41 | -197.49 | -138.57 | Upgrade
|
| Free Cash Flow Margin | -601.74% | -928.71% | 98.73% | -6.34% | -258.60% | -1712.67% | Upgrade
|
| Free Cash Flow Per Share | -3.49 | -5.97 | 11.83 | -0.52 | -1.66 | -4.57 | Upgrade
|
| Cash Income Tax Paid | - | -2.68 | 252.03 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -356.99 | -596.45 | 1,469 | -246.55 | -138.07 | -77.96 | Upgrade
|
| Unlevered Free Cash Flow | -356.99 | -596.45 | 1,469 | -246.55 | -138.07 | -77.96 | Upgrade
|
| Change in Net Working Capital | 113.8 | 293.13 | -907.22 | 577.3 | -20.53 | -28.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.